WeHand
Daxing · Founded 2010
About WeHand
WeHand is a biopharmaceutical company that focuses on innovative drugs for major diseases such as metabolic diseases, malignant tumors, anti-inflammatory immunity, and so on. WeHand focuses on strategic planning and top-level design, adheres to the concept of open cooperation and innovative development, integrates multidisciplinary and cross-field systems, and quickly transforms original technology into products and realizes commercial value through the incubation of original innovative drugs, high-standard clinical research, and customized intelligent production lines.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2017)
- Website: http://www.wehandbio.com
- Phone: 010-89285047
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/wehand-126058 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.